Italia markets closed

BMY Jul 2024 37.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,19000,0000 (0,00%)
In data: 09:35AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1900
Aperto0,1900
Denaro0,1800
Domanda0,2200
Prezzo d'esercizio37,00
Scadenza2024-07-19
Min-Max giorno0,1900 - 0,1900
Contratto - Min-MaxN/D
Volume1
Open Interest556
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri